Literature DB >> 4486599

Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.

K E Price, D R Chisholm, M Misiek, F Leitner, Y H Tsai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4486599     DOI： 10.7164/antibiotics.25.709

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  21 in total

1.  Penetration of amikacin into the aphakic eye.

Authors:  R T Kasbeer; G A Peyman; D R May; P I Homer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-08-04

2.  In vitro additive effect of polymxin B and rifampin against Serratia marcesen.

Authors:  W H Traub; I Kleber
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

3.  Comparative ototoxicity of amikacin and gentamicin in cats.

Authors:  E F Christensen; J C Reiffenstein; H Madissoo
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin.

Authors:  T Madhavan; K Yaremchuk; N Levin; D Pohlod; K Burch; E Fisher; F Cox; E L Quinn
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.

Authors:  M G Myers; R J Roberts; N J Mirhij
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

6.  Ototoxicity of amikacin.

Authors:  R E Black; W K Lau; R J Weinstein; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

7.  Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups.

Authors:  R Benveniste; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

8.  Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.

Authors:  P B Marengo; M E Chenoweth; G D Overturf; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Pharmacology of amikacin in humans.

Authors:  G P Bodey; M Valdivieso; R Feld; V Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

10.  Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.

Authors:  P M Sharp; C A Saenz; R R Martin
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.